Literature DB >> 18460956

Carbon monoxide poisoning: how many patients do we miss?

Ayfer Keleş1, Ahmet Demircan, Gülhan Kurtoğlu.   

Abstract

INTRODUCTION: Carbon monoxide (CO) is a colorless, odorless and nonirritating gas. CO poisoning is a preventable cause of morbidity and mortality. After the late diagnosis of some CO-poisoned patients, we undertook a chart review to identify characteristics of patients with CO poisoning to help with management of future patients.
METHODS: We retrospectively evaluated the charts of 323 adult emergency department patients diagnosed with CO poisoning between January 2002 and December 2003. Demographic, clinical and laboratory findings were extracted. Chi square test was used to evaluate the correlation between carboxyhemoglobin (COHb) levels and syncope; and between syncope and sex.
RESULTS: The mean age of the 323 patients was 29+/-17 years, and most (64%) were females. All of the poisonings were unintentional, and most patients presented during the winter months. The most common sources of CO were coal stoves (29%) and water heaters (24%). Complaints were headache in 55%, nausea in 49%, dizziness in 44%, syncope in 28%, and seizures in 4%. Abnormal physical findings included tachypnea in 79% and tachycardia in 47%. The mean COHb value was 26.3+/-11.5%. Syncope occurred more frequently in patients with high COHb levels (P<0.001) and was more common among females (P=0.003). Seizures occurred significantly more often in patients with a COHb level of > or =20%.
CONCLUSION: CO exposure in our patients was acute, accidental, and occurred during the winter months. Serious symptoms, such as syncope, occurred more often in patients having increased COHb levels, but normal COHb levels could not be used to rule out CO poisoning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460956     DOI: 10.1097/MEJ.0b013e3282efd519

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  8 in total

Review 1.  The Diagnosis and Treatment of Carbon Monoxide Poisoning.

Authors:  Lars Eichhorn; Marcus Thudium; Björn Jüttner
Journal:  Dtsch Arztebl Int       Date:  2018-12-24       Impact factor: 5.594

2.  Factors that influence the decision for hyperbaric oxygen therapy (HBOT) in cases of carbon monoxide poisoning: a retrospective study.

Authors:  I Altintop; M E Akcin; M Tatli; M S Ilbasmis
Journal:  Ann Burns Fire Disasters       Date:  2018-09-30

Review 3.  Syncope and Headache.

Authors:  Ramesh K Khurana
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

Review 4.  TiTrATE: A Novel, Evidence-Based Approach to Diagnosing Acute Dizziness and Vertigo.

Authors:  David E Newman-Toker; Jonathan A Edlow
Journal:  Neurol Clin       Date:  2015-08       Impact factor: 3.806

5.  The roles of glucose-6-phosphate dehydrogenase deficiency and ventilation support in outcome of carbon monoxide poisoning.

Authors:  Ebrahim Alijanpour; Ali Jabbari; Shabnam Tabasi
Journal:  Anesth Essays Res       Date:  2011 Jan-Jun

6.  S2k guideline diagnosis and treatment of carbon monoxide poisoning.

Authors:  Björn Jüttner; Hans-Jörg Busch; Andreas Callies; Harald Dormann; Thorsten Janisch; Guido Kaiser; Hella Körner-Göbel; Karsten Kluba; Stefan Kluge; Bernd A Leidel; Oliver Müller; Johannes Naser; Carsten Pohl; Karl Reiter; Dietmar Schneider; Enrico Staps; Wilhelm Welslau; Holger Wißuwa; Gabriele Wöbker; Cathleen Muche-Borowski
Journal:  Ger Med Sci       Date:  2021-11-04

7.  Accidental carbon monoxide poisoning in our homes.

Authors:  Shruti Sharma; Rahul Gupta; Barinder S Paul; Sandeep Puri; Shuchita Garg
Journal:  Indian J Crit Care Med       Date:  2009 Jul-Sep

8.  Screening for carbon monoxide exposure in selected patient groups attending rural and urban emergency departments in England: a prospective observational study.

Authors:  Simon Clarke; Catherine Keshishian; Virginia Murray; George Kafatos; Ruth Ruggles; Elizabeth Coultrip; Sam Oetterli; Daniel Earle; Patricia Ward; Stephen Bush; Crispin Porter
Journal:  BMJ Open       Date:  2012-12-13       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.